This announcement is a separate document:
信永中和会计师事务所(特殊普通合伙)关于《关于广誉远中药股份有限公司 2023年年度报告的信息披露监管工作函》的回复
Reply from Ernst & Young Zhonghe Certified Public Accountants (Special General Partnership) regarding the Information Disclosure and Supervision Letter on the Annual Report of Guangyuyuan Chinese Herbal Medicine Co., Ltd. for the year 2023.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.